SCHEMBL5829663

SCHEMBL5829663

CC(C)c1c(C(N)=O)ccc(N(c2cc(C(N)=O)ccc2F)C2CCN(Cc3cccnc3)CC2)c1C(C)C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.42
PARP1 P09874 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
OPRM1 P35372 4/20 0.41
OPRD1 P41143 3/20 0.41
OPRK1 P41145 3/20 0.41
CACNA1I Q9P0X4 1/20 0.40
UBE2M P61081 3/20 0.40
DCUN1D1 Q96GG9 3/20 0.40
KMT2A Q03164 1/20 0.39
CHRM3 P20309 1/20 0.39
CYP3A4 P08684 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KDM4E B2RXH2 1/20 0.38
SLC18A3 Q16572 2/20 0.38
F2 P00734 1/20 0.38
F10 P00742 1/20 0.38
SLC6A5 Q9Y345 1/20 0.38
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5828656 0.90 OPRM1 (0.41) PARP1OPRM1OPRD1OPRK1KCNH2
SCHEMBL5830260 0.87 PARP1 (0.46) DRD4PARP1PARP2OPRM1OPRD1
SCHEMBL5829647 0.85 PARP1 (0.42) DRD4PARP1OPRM1OPRD1OPRK1
SCHEMBL5829616 0.84 PARP1 (0.40) PARP1PARP2OPRM1OPRD1OPRK1
SCHEMBL5829936 0.84 PARP2 (0.40) PARP2OPRM1OPRD1OPRK1CHRM3
SCHEMBL5829605 0.83 PARP1 (0.43) DRD4PARP1PARP2OPRM1OPRD1
SCHEMBL5829658 0.83 OPRD1 (0.51) OPRM1OPRD1OPRK1UBE2MDCUN1D1
SCHEMBL5879381 0.80 OPRD1 (0.63) OPRM1OPRD1OPRK1
SCHEMBL5829864 0.78 PARP1 (0.44) PARP1PARP2OPRM1OPRD1OPRK1
SCHEMBL5631262 0.78 OPRD1 (0.61) OPRM1OPRD1OPRK1KMT2ACHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7008952-B2 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders ASTRAZENECA AB (SE) 2006-03-07 US claimed